ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

CLL Cello Health Plc

161.00
0.00 (0.00%)
28 Mar 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Cello Health Plc LSE:CLL London Ordinary Share GB00B0310763 ORD 10P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 161.00 0.00 00:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

SAND GROVE CAPITAL: Form 8.3 - Cello Health Plc

03/07/2020 3:00pm

UK Regulatory


Cello Health (LSE:CLL)
Historical Stock Chart


From Mar 2019 to Mar 2024

Click Here for more Cello Health Charts.
TIDMCLL 
 
 

FORM 8.3

 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

 

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

 

Rule 8.3 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 
(a) Full name of discloser:             Sand Grove Capital Management LLP 
(b) Owner or controller of interests    Fund(s) for whom Sand Grove Capital 
and short positions disclosed, if       Management LLP is the Investment 
different from 1(a): The naming of      Manager 
nominee or vehicle companies is 
insufficient. For a trust, the 
trustee(s), settlor and beneficiaries 
must be named. 
(c) Name of offeror/offeree in          Cello Health plc 
relation to whose relevant securities 
this form relates: Use a separate form 
for each offeror/offeree 
(d) If an exempt fund manager 
connected with an offeror/offeree, 
state this and specify identity of 
offeror/offeree: 
(e) Date position held/dealing          2 July 2020 
undertaken: For an opening position 
disclosure, state the latest 
practicable date prior to the 
disclosure 
(f) In addition to the company in 1(c)  N/A 
above, is the discloser making 
disclosures in respect of any other 
party to the offer? If it is a cash 
offer or possible cash offer, state 
"N/A" 
 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 
Class of relevant security:                10p ordinary 
                                           Interests         Short positions 
                                           Number     %      Number        % 
(1) Relevant securities owned and/or 
controlled: 
(2) Cash-settled derivatives:              1,818,900  1.70% 
(3) Stock-settled derivatives (including 
options) and agreements to 
purchase/sell: 
 
 TOTAL:                                    1,818,900  1.70% 
 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

(b) Rights to subscribe for new securities (including directors' and other employee options)

 
Class of relevant security in relation to which subscription right exists: 
Details, including nature of the rights concerned and relevant percentages: 
 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 
Class of relevant          Purchase/sale  Number of securities  Price per unit 
security 
 
 
 

(b) Cash-settled derivative transactions

 
                              Nature of dealing 
                              e.g. opening/closing 
                              a long/short 
                              position, 
Class of       Product        increasing/reducing   Number of 
relevant       description    a long/short          reference     Price per 
security       e.g. CFD       position              securities    unit 
                              Increasing a long 
10p ordinary   CFD             position             1,385,000     163.00 
 
 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 
Class of  Product      Writing,     Number of   Exercise  Type e.g.  Expiry  Option 
relevant  description  purchasing,  securities  price     American,  date    money 
security  e.g. call    selling,     to which    per       European           paid/ 
          option       varying      option      unit      etc.               received 
                       etc.         relates                                  per 
                                                                             unit 
 
 

(ii) Exercise

 
Class of        Product         Exercising/     Number of       Exercise price 
relevant        description     exercised       securities      per unit 
security        e.g. call       against 
                option 
 
 

(d) Other dealings (including subscribing for new securities)

 
Class of relevant       Nature of dealing      Details  Price per unit (if 
security                e.g. subscription,              applicable) 
                        conversion 
 
 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 
Details of any indemnity or option arrangement, or any agreement or 
understanding, formal or informal, relating to relevant securities which may 
be an inducement to deal or refrain from dealing entered into by the person 
making the disclosure and any party to the offer or any person acting in 
concert with a party to the offer: Irrevocable commitments and letters of 
intent should not be included. If there are no such agreements, arrangements 
or understandings, state "none" 
 
 None 
 

(b) Agreements, arrangements or understandings relating to options or derivatives

 
Details of any agreement, arrangement or understanding, formal or informal, 
between the person making the disclosure and any other person relating to: (i) 
the voting rights of any relevant securities under any option; or (ii) the 
voting rights or future acquisition or disposal of any relevant securities to 
which any derivative is referenced: If there are no such agreements, 
arrangements or understandings, state "none" 
 
 None 
 

(c) Attachments

 
Is a Supplemental Form 8 (Open Positions) attached?  No 
 
 
Date of disclosure:   3 July 2020 
Contact name:         Pau Gimeno Perramon 
Telephone number:     +44 203 770 8623 
 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

*If the discloser is a natural person, a telephone number does not need to be included, provided contact information has been provided to the Panel's Market Surveillance Unit.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20200703005144/en/

 
    CONTACT: 

Sand Grove Capital Management LLP

 
    SOURCE: Sand Grove Capital Management LLP 
Copyright Business Wire 2020 
 

(END) Dow Jones Newswires

July 03, 2020 10:00 ET (14:00 GMT)

1 Year Cello Health Chart

1 Year Cello Health Chart

1 Month Cello Health Chart

1 Month Cello Health Chart

Your Recent History

Delayed Upgrade Clock